🇺🇸 FDA
Patent

US 10189825

Heteroaryl compounds and methods of use thereof

granted A61PA61P1/08A61P15/00

Quick answer

US patent 10189825 (Heteroaryl compounds and methods of use thereof) held by PGI Drug Discovery LLC expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PGI Drug Discovery LLC
Grant date
Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P1/08, A61P15/00, A61P15/10, A61P25/00